(Q31110269)

28 June 2017

title

Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base (English)

1 reference

28 June 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27337679%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jaleh Fallah

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27337679%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jorge Castillo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27337679%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Adam J Olszewski

1

1 reference

28 June 2017

Jaleh Fallah

2

1 reference

28 June 2017

Jorge J Castillo

3

1 reference

28 June 2017

language of work or name

English

0 references

publication date

23 June 2016

1 reference

28 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27337679%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27337679%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27337679%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

2689-2697

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27337679%20AND%20SRC:MED&resulttype=core&format=json

Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

How I treat HIV-associated lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Cancer treatment disparities in HIV-infected individuals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

The National Cancer Data Base: a powerful initiative to improve cancer care in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Multiple imputation using chained equations: Issues and guidance for practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Low-intensity therapy in adults with Burkitt's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Service Delivery and Patient Outcomes in Ryan White HIV/AIDS Program-Funded and -Nonfunded Health Care Facilities in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Non-Hodgkin's lymphomas, version 4.2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

A new prognostic score for AIDS-related lymphomas in the rituximab-era

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Long-Term Remission of HIV-Associated Primary CNS Lymphoma Achieved With Highly Active Antiretroviral Therapy Alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

Implications of the shifting pathobiology of AIDS-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30112

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.30112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27337679%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference